Thrombin-Induced Platelet-Fibrin Clot Strength Identified by Thrombelastography

Cardiovascular Disease in African American Women: A Health Care Disparities Issue

(2016) Richard Allen Williams   JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION

Pharmacological inhibition of coronary restenosis: systemic and local approaches

(2014) Elena Guerra et al.   EXPERT OPINION ON PHARMACOTHERAPY

4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents

(2014) Masanori Taniwaki et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Influence of Race and Sex on Thrombogenicity in a Large Cohort of Coronary Artery Disease Patients

(2014) Eli I. Lev et al.   Journal of the American Heart Association

Association of baseline high-density lipoprotein levels with restenosis after coronary stenting

(2013) Wen-Jun He et al.   CORONARY ARTERY DISEASE

Baseline LDL-C and Lp(a) Elevations Portend a High Risk of Coronary Revascularization in Patients after Stent Placement

(2013) Anping Cai et al.   DISEASE MARKERS

Final 5-Year Outcomes From the Endeavor Zotarolimus-Eluting Stent Clinical Trial Program

(2013) David E. Kandzari et al.   JACC-Cardiovascular Interventions

One-year outcomes of consecutive patients treated by endeavor zotarolimus and resolute zotarolimus stents: The impact of polymer coating in drug-eluting stent technology

(2012) Giovanni Paolo Talarico et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Two zotarolimus-eluting stent generations: a meta-analysis of 12 randomised trials versus other limus-eluting stents and an adjusted indirect comparison

(2012) Salvatore Cassese et al.   HEART

Stent implantation in the superficial femoral artery: Short thrombelastometry-derived coagulation times identify patients with late in-stent restenosis

(2012) Gerhard Cvirn et al.   THROMBOSIS RESEARCH

Lipoprotein(a) in Cardiovascular Diseases

(2012) Michele Malaguarnera et al.   Biomed Research International

Restenosis

(2011) Vasim Farooq et al.   Circulation-Cardiovascular Interventions

Type 2 diabetes and cardiovascular risk factors

(2011) Morali D. Sharma et al.   CURRENT MEDICAL RESEARCH AND OPINION

Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents

(2010) Stefanie Schulz et al.   AMERICAN HEART JOURNAL

Oxidized-LDL/β2-Glycoprotein I Complexes Are Associated With Disease Severity and Increased Risk for Adverse Outcomes in Patients With Acute Coronary Syndromes

(2010) Thomas P. Greco et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

High-density lipoproteins: Marker of cardiovascular risk and therapeutic target

(2010) Peter P. Toth et al.   Journal of Clinical Lipidology

C-Reactive Protein and the Risk of Stent Thrombosis and Cardiovascular Events After Drug-Eluting Stent Implantation

(2009) Duk-Woo Park et al.   CIRCULATION

Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease

(2009) Paul A. Gurbel et al.   CIRCULATION

Comparison of Effects of Simvastatin Alone Versus Fenofibrate Alone Versus Simvastatin Plus Fenofibrate on Lipoprotein Subparticle Profiles in Diabetic Patients With Mixed Dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen Study)

(2008) Heidi T. May et al.   AMERICAN JOURNAL OF CARDIOLOGY

Effects of Increasing Particle Size of Low-Density Lipoprotein on Restenosis After Coronary Stent Implantation

(2008) Jung-Sun Kim et al.   CIRCULATION JOURNAL

Comparison of inflammatory markers and angiographic outcomes after implantation of sirolimus and paclitaxel-eluting stents

(2008) W C Kang et al.   HEART

Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent

(2007) Kishore Udipi et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

Relevance of hemostasis on restenosis in clinically stable patients undergoing elective PTCA

(2007) F.C. Schoebel et al.   THROMBOSIS RESEARCH